CureVac N.V. (LON:0A9E)
3.640
+0.195 (5.66%)
At close: May 2, 2025
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
489.58K GBP
Profits / Employee
148.37K GBP
Market Cap
602.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
Shell | 96,000 |
HSBC Holdings | 211,304 |
Unilever | 115,964 |
Rio Tinto Group | 60,000 |
RELX PLC | 36,400 |
British American Tobacco p.l.c. | 48,989 |
Rolls-Royce Holdings | 42,400 |
CureVac News
- 24 days ago - CureVac N.V. (CVAC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - CureVac BV reports Q4 results - Seeking Alpha
- 24 days ago - CureVac N.V. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 24 days ago - CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update - Accesswire
- 25 days ago - Earnings Scheduled For April 10, 2025 - Benzinga
- 25 days ago - Insights Ahead: CureVac's Quarterly Earnings - Benzinga
- 26 days ago - CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025 - Accesswire
- 27 days ago - CureVac to initiate Phase 1 trial for its lung cancer therapy - Seeking Alpha